MAIN MENU
QUICK LINKS
CONNECT WITH US

Button
Coronavirus (COVID-19) updates, visitor restrictions and resources →
Now offering telemedicine through our Virtual Visit online program for primary care and specialty care visits → Virtual Visit appointments are available for new and existing UF Health patients. Check the FAQ section and Request an Appointment section below for more information.

Call (904) 383-1052 to make an appointment or call your physician’s office if you have questions specific to your health needs.

Clinical Trial Details

Title
IIS 53376 Adjunctive Vorapaxar Therapy in Patients with Prior Myocardial Infarction Treated with New Generation P2Y12 Receptor Inhibitors Prasugrel and Ticagrelor (VORA-PRATIC): A Prospective, Randomized, Pharmacodynamic Study
Study Description

The purpose of this study is to evaluate the effect of Zontivity® in addition to either Brilinta® or Effient® with and without aspirin

Subjects participating in this study will be randomized (like a flip of a coin) either to receive Zontivity® in addition to their standard blood thinning medication with or without aspirin or to continue their therapy without any change. Afterwards subjects will receive your standard-of-care therapy.

Open Enrollment
Contact Name: Andrea Goosen
Contact Phone: (904) 244-5617
Contact Email: Andrea.Goosen@jax.ufl.edu
Investigators

Principal Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Francesco Franchi, M.B.Ch.B. (M.D.)
Medicine

Sub Investigator
Fabiana Rollini, M.B.Ch.B. (M.D.)
Medicine